Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06876896 · ClinicalTrials.gov registry record · NA

Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter

A NA study of Intra-Abdominal Hypertension, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06876896: Recruiting NA study of Intra-Abdominal Hypertension, sponsored by Wake Forest University Health Sciences.

NCT06876896 is a NA study of Intra-Abdominal Hypertension that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06876896, a NA study of Intra-Abdominal Hypertension, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the intra-abdominal pressure utilizing the Accuryn monitoring system during pulsed field ablation procedures in the electrophysiology lab compared to the type of anesthetic utilized.

Primary Outcome

intra-abdominal pressure during PFA when general anesthetic is utilized

Interventions

  • DEVICE Accuryn Foley catheter device

Study Locations (1)

North Carolina

  • Wake Forest Health Sciences - Winston-Salem

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-03-03
Est. Completion 2026-12-30
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What NCT06876896 shows while recruiting

NCT06876896 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Intra-Abdominal Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Accuryn Foley catheter device is the first listed.

NCT06876896 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06876896 about?

NCT06876896 is a clinical study titled "Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter". The purpose of this study is to investigate the intra-abdominal pressure utilizing the Accuryn monitoring system during pulsed field ablation procedures in the electrophysiology lab compared to the type of anesthetic utilized.

What is the current status of trial NCT06876896?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-03-03. Estimated completion is 2026-12-30.

What conditions does trial NCT06876896 study?

This clinical trial studies the following conditions: Intra-Abdominal Hypertension.

What interventions are being tested in trial NCT06876896?

The interventions under investigation include: Accuryn Foley catheter device (DEVICE).

Who is sponsoring clinical trial NCT06876896?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06876896 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intra-Abdominal Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06876896's enrollment target sits among peer trials

50 1280th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06876896, the US trial registry maintained by the National Library of Medicine. NCT06876896 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.